| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |